Indeed, tumor cells in 3 of 4 dogs with “mixed lineage” leukemias were positive for multiple myeloid-associated antigens, including CD80, favoring an AML with aberrant, typically weak, lymphoid antigen expression. This evidence concerns the gene CD80 and neoplasm.